Fundraising FoxSanmirna
Amsterdam, US · 1 known investors
Find your way into Sanmirna
Sign up to find every way you can get introduced to Sanmirna
- Your email: who you already know at Sanmirna, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sanmirna team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Sanmirna Therapeutics develops microRNA-targeted therapeutics for cancer treatment, with its lead candidate Miristen™ currently in Phase I clinical trials for acute myeloid leukemia. The company leverages microRNA discovery to create novel oncology treatments.
Investors · 1
NLClisted by NLCAmsterdam
How we know: NLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does Sanmirna do?
- Sanmirna Therapeutics develops microRNA-targeted therapeutics for cancer treatment, with its lead candidate Miristen™ currently in Phase I clinical trials for acute myeloid leukemia. The company leverages microRNA discovery to create novel oncology treatments.
- Who are Sanmirna's investors?
- Sanmirna's investors include NLC.
- Where is Sanmirna headquartered?
- Sanmirna is headquartered in Amsterdam, US.